Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Connolly

Showing results (841-850 of 1,370) with videos related to

Pageof 137
Sort By:
Journal of Neural Engineering|April 16, 2021
Multi-objective data-driven optimization for improving deep brain stimulation in Parkinson's diseaseMark J Connolly, Eric R Cole, Faical Isbaine, et al.
Drug Testing and Analysis|October 30, 2023
In vitro cannabinoid activity profiling of generic ban-evading brominated synthetic cannabinoid receptor agonists and their analogsMarie H Deventer, Mattias Persson, Caitlyn Norman, et al.
International Journal of Cardiology|May 15, 2007
Potential demographic and baselines variables for risk stratification of high-risk post-myocardial infarction patients in the era of implantable cardioverter-defibrillator--a prognostic indicatorYee Guan Yap, Trinh Duong, Martin Bland, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 29, 2007
Endogenous endostatin inhibits choroidal neovascularizationAlexander G Marneros, Haicheng She, Hadi Zambarakji, et al.
The American Journal of Cardiology|July 11, 2006
Efficacy of azimilide for the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation in the presence and absence of structural heart diseaseCharles R Kerr, Stuart J Connolly, Peter Kowey, et al.
The New England Journal of Medicine|December 14, 2004
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarctionStefan H Hohnloser, Karl Heinz Kuck, Paul Dorian, et al.
American Heart Journal|December 19, 2015
Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillationJulia Aulin, Agneta Siegbahn, Ziad Hijazi, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Apixaban-Calibrated Anti-FXa Activity in Relation to Outcome Events and Clinical Characteristics in Patients with Atrial Fibrillation: Results from the AVERROES TrialVinai C Bhagirath, John W Eikelboom, Jack Hirsh, et al.
Clinical Cardiology|November 9, 2005
Prognostic impact of demographic factors and clinical features on the mode of death in high-risk patients after myocardial infarction--a combined analysis from multicenter trialsYee Guan Yap, Trinh Duong, J Martin Bland, et al.
The Journal of Clinical Endocrinology and Metabolism|January 12, 2010
Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled studyUpendram Srinivas-Shankar, Stephen A Roberts, Martin J Connolly, et al.
Pageof 137

Showing results (841-850 of 1,370) with videos related to

Sort By:
Pageof 137
Journal of Neural Engineering|April 16, 2021
Multi-objective data-driven optimization for improving deep brain stimulation in Parkinson's diseaseMark J Connolly, Eric R Cole, Faical Isbaine, et al.
Drug Testing and Analysis|October 30, 2023
In vitro cannabinoid activity profiling of generic ban-evading brominated synthetic cannabinoid receptor agonists and their analogsMarie H Deventer, Mattias Persson, Caitlyn Norman, et al.
International Journal of Cardiology|May 15, 2007
Potential demographic and baselines variables for risk stratification of high-risk post-myocardial infarction patients in the era of implantable cardioverter-defibrillator--a prognostic indicatorYee Guan Yap, Trinh Duong, Martin Bland, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 29, 2007
Endogenous endostatin inhibits choroidal neovascularizationAlexander G Marneros, Haicheng She, Hadi Zambarakji, et al.
The American Journal of Cardiology|July 11, 2006
Efficacy of azimilide for the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation in the presence and absence of structural heart diseaseCharles R Kerr, Stuart J Connolly, Peter Kowey, et al.
The New England Journal of Medicine|December 14, 2004
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarctionStefan H Hohnloser, Karl Heinz Kuck, Paul Dorian, et al.
American Heart Journal|December 19, 2015
Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillationJulia Aulin, Agneta Siegbahn, Ziad Hijazi, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Apixaban-Calibrated Anti-FXa Activity in Relation to Outcome Events and Clinical Characteristics in Patients with Atrial Fibrillation: Results from the AVERROES TrialVinai C Bhagirath, John W Eikelboom, Jack Hirsh, et al.
Clinical Cardiology|November 9, 2005
Prognostic impact of demographic factors and clinical features on the mode of death in high-risk patients after myocardial infarction--a combined analysis from multicenter trialsYee Guan Yap, Trinh Duong, J Martin Bland, et al.
The Journal of Clinical Endocrinology and Metabolism|January 12, 2010
Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled studyUpendram Srinivas-Shankar, Stephen A Roberts, Martin J Connolly, et al.
Pageof 137